Effect of Dipeptidyl Peptidase-4 Inhibitors vs. Metformin on Major Cardiovascular Events Using Spontaneous Reporting System and Real-World Database Study.

Noguchi, Yoshihiro; Yoshizawa, Shunsuke; Tachi, Tomoya; Teramachi, Hitomi

Noguchi, Yoshihiro; Yoshizawa, Shunsuke; Tachi, Tomoya; Teramachi, Hitomi.

Afiliación

Noguchi Y; Laboratory of Clinical Pharmacy, Gifu Pharmaceutical University, 1-25-4, Daigakunishi, Gifu-shi 501-1196, Japan.
Yoshizawa S; Laboratory of Clinical Pharmacy, Gifu Pharmaceutical University, 1-25-4, Daigakunishi, Gifu-shi 501-1196, Japan.
Tachi T; Laboratory of Clinical Pharmacy, Gifu Pharmaceutical University, 1-25-4, Daigakunishi, Gifu-shi 501-1196, Japan.
Teramachi H; Laboratory of Clinical Pharmacy, Gifu Pharmaceutical University, 1-25-4, Daigakunishi, Gifu-shi 501-1196, Japan.

J Clin Med ; 11(17)2022 Aug 25.

Article en En | MEDLINE | ID: mdl-36078917

Palabras clave

dipeptidyl peptidase-4 inhibitors; disproportionality analysis; major cardiovascular events; metformin; real-world evidence study

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Clin Med Año: 2022 Tipo del documento: Article País de afiliación: Japón

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google